IRD
Opus Genetics
IRD
IRD
41 hedge funds and large institutions have $13M invested in Opus Genetics in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 35 → 41 (+6)
1.72% more ownership
Funds ownership: 14.89% → 16.61% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
41
Holding in Top 10
1
Calls
$76K
Puts
$6K
Top Buyers
| 1 | +$538K | |
| 2 | +$375K | |
| 3 | +$205K | |
| 4 |
DC
Diametric Capital
Boston,
Massachusetts
|
+$120K |
| 5 |
TCOT
Trust Company of Toledo
Holland,
Ohio
|
+$97.5K |
Top Sellers
| 1 | -$128K | |
| 2 | -$73.1K | |
| 3 | -$57.9K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$52.7K |
| 5 |
Morgan Stanley
New York
|
-$17K |